SCI & TECH● LOWSep 1 · Sep 1, 2026, 6:24 PM
AstraZeneca, Hutchmed succeed in late-stage lung cancer trial for Orpathys, Tagrisso combo
Seeking Alpha Tech · global
AstraZeneca and Hutchmed have announced successful late-stage clinical trial results for a combination therapy involving Orpathys and Tagrisso for lung cancer. This marks a significant advancement in cancer treatment research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH34m agoResearchers use ChatGPT-style technology to predict stroke risk from a person’s DNAEuroNews [en]SCI & TECH1h agoHow planting a 'rain garden' could help protect your home from floodingEuroNews [en]SCI & TECH1h agoMicrosoft Surface Laptop Ultra : What the reviews tell ustechradar.com · United KingdomSCI & TECH1h agoDiamonds are forever , but what about soil ? hub-4.com · United Kingdom